The aim of report is to show the Days of therapy (DOTs) and Defined Daily Dose (DDDs) and quartrly expenditures for selected antibiotics in 2018. The antibiotics selected by antibiotic committee are:
1. Meropenem 1 gm and 500 mg inj.
2. Colistin sulfomethate sodium 1 MU and 0.5 MU inj.
3. Anidulafungin 100 mg/30 ml inj.
4. Caspofungin 70 mg and 50 mg inj.
5. Tigecycline 50 mg inj.
6. Linezolid 600 mg inj.
7. Vancomycin 500 mg inj.
8. Piperacillin/Tazobactam 2.25 gm and 4.5 gm inj.
Calculate DDD, DOTs, Expenditure.SAR for each quarter. following these formulas:
For Defined Daily Dose \[DDD = \sum_{for all patients} Quantity_{dispensed}/frequency\]
For Days of Therapy
\[DOT = Count_{unique}(MRN * Issue.date)\]
For Quarter Expenditures
\[Expenditure.SAR = Quantity * Unit price\]
Calculate DDD1000 (Defined Daily Dose per 1000 patient days) , DOT1000 (Days Of Therapy per 1000 patient days) and Expenditure.SAR1000 (Expenditure.SAR per 1000 patient days).
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 44.677 | 43.397 | 132895.35 |
| 2nd quarter | 38.261 | 45.506 | 124776.66 |
| 3rd quarter | 29.991 | 39.095 | 100247.47 |
| 4th quarter | 18.464 | 22.239 | 56460.71 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 17.658 | 6.082 | 32114.25 |
| 2nd quarter | 18.288 | 8.279 | 37563.75 |
| 3rd quarter | 11.929 | 4.200 | 24774.75 |
| 4th quarter | 19.995 | 4.350 | 35453.25 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 0.509 | 0.424 | 13041.0 |
| 2nd quarter | 0.762 | 0.457 | 21735.0 |
| 3rd quarter | 1.247 | 0.764 | 35500.5 |
| 4th quarter | 0.665 | 0.563 | 18837.0 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 0.764 | 0.255 | 52205.46 |
| 2nd quarter | 0.203 | 0.203 | 15568.52 |
| 3rd quarter | 0.764 | 0.764 | 57990.24 |
| 4th quarter | 0.486 | 0.179 | 36684.42 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 3.862 | 3.480 | 46875.0 |
| 2nd quarter | 4.177 | 4.673 | 58312.5 |
| 3rd quarter | 1.514 | 1.604 | 21187.5 |
| 4th quarter | 2.175 | 1.663 | 30375.0 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 1.188 | 2.603 | 21763.48 |
| 2nd quarter | 1.807 | 2.539 | 33399.40 |
| 3rd quarter | 1.226 | 1.604 | 24349.24 |
| 4th quarter | 0.883 | 1.382 | 17669.36 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 30.457 | 22.123 | 414368.0 |
| 2nd quarter | 27.561 | 21.103 | 386355.6 |
| 3rd quarter | 22.375 | 17.155 | 299732.7 |
| 4th quarter | 26.387 | 20.038 | 364376.7 |
| Quarter 2018 | DDD1000 | DOT1000 | Expenditures.SAR1000 |
|---|---|---|---|
| 1st quarter | 13.565 | 15.871 | 27249.11 |
| 2nd quarter | 11.675 | 17.928 | 27527.73 |
| 3rd quarter | 16.676 | 23.187 | 39500.23 |
| 4th quarter | 11.640 | 17.402 | 28607.97 |
| Patient days | |
|---|---|
| Jan | 12071 |
| Feb | 11152 |
| Mar | 12125 |
| Apr | 12670 |
| May | 14256 |
| Jun | 12453 |
| Jul | 13298 |
| Aug | 13297 |
| Sep | 12694 |
| Oct | 13498 |
| Nov | 12617 |
| Dec | 12961 |
| Antibiotic | Unit price in SAR |
|---|---|
| Meropenem 1gm | 19.53 |
| Meropenem 500 mg | 37.991 |
| Colistin 0.5 MU | 15.75 |
| Anidulafungin | 724.5 |
| Caspofungin 70 mg | 1975.74 |
| Caspofungin 50 mg | 1928.26 |
| Tigecyclin 50 mg | 187.5 |
| Linezolide 600 mg | 215.48 |
| Vancomycin 500 mg | 5.5916 |
| Tazocin 2.25 gm | 14.69 |
| Tazocin 4.5 gm | 20.77 |
| Antibiotic | Number of entries per antibiotic |
|---|---|
| Meropenem 1gm/500mg | 5949 |
| Colistin 0.5 MU | 896 |
| Anidulafungin | 92 |
| Caspofungin 70 mg/50 mg | 54 |
| Tigecyclin 50 mg | 461 |
| Linezolide 600 mg | 314 |
| Vancomycin 500 mg | 3316 |
| Tazocin 2.25 gm /4.5 gm | 2952 |